UNSPSC 85602506: Revision of autologous tissue substitute in large intestine, via natural or artificial opening

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of autologous tissue substitute in large intestine, via natural or artificial opening. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0DWE77Z

UNSPSC 85602506 Revision of autologous tissue substitute in large intestine, via natural or artificial opening is a Commodity code showing no relevant recent state and local procurement activity. Six recent opportunities posted across Arizona, California, Washington, and Florida between July and September 2026 under this code are all tagged to independent medical evaluation services, occupational health surveillance, pharmacy benefit management, temporary health professional staffing, specialty medical carve-out programs, and youth detention healthcare — none of which involve tissue substitutes, intestinal revision procedures, autologous materials, or surgical interventions aligned with the code's nominal scope. The mismatch indicates either persistent miscoding by issuing bodies or that this Commodity code does not map to actual state and local procurement practice in the market.

No representative solicitations match the substance of this code. The City of Phoenix Retirement Office (RTMRFP26001, RFP, due October 16, 2026) sought disability medical record summarization and independent medical evaluations for pension benefit determinations; the Washington State Department of Transportation (RFP20260825, RFP, due October 9, 2026) procured occupational medical surveillance for ferries employees; the County of Santa Clara Health System (RFSQHHSFY270052, RFP, due October 7, 2026) established a qualified vendor pool for temporary ancillary health professional staffing; and Collier County (RFP 25-8414, RFP, due April 9, 2026) purchased pharmacy benefit management services. None involve the tissue-based procedures this code nominally describes. Business development professionals should verify code alignment with the issuing body before pursuing opportunities tagged to this Commodity, as recent activity suggests systematic miscoding rather than genuine demand for autologous tissue substitutes in large-intestine revision within state and local government.